KRAS and BRAF gene mutations and DNA mismatch repair status in Chinese colorectal carcinoma patients

doi:10.3748/wjg.v21.i5.1595

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 21, Issue 5

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (9118)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-6) series.

Item

Count

PDF

606

WORD

340

HTML

5673

Figures (1-2)

249

Tables (1-6)

190

Sum=7058

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1122

Download

938

Sum=2060

Feb 7, 2015 (publication date) through Nov 25, 2024

Times Cited of This Article

Times Cited (38)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Gastroenterol. Feb 7, 2015; 21(5): 1595-1605
Published online Feb 7, 2015. doi: 10.3748/wjg.v21.i5.1595

Table 4 Correlations between KRAS and BRAF status and clinicopathological features n (%)

Clinicopathological feature	KRAS		BRAF
Clinicopathological feature	Mutant/tested cases	P value	Mutant/tested cases	P value
Gender
Male	100/277 (36.1)	0.336	7/254 (2.8)	0.048
Female	84/208 (40.4)	0.336	13/196 (6.6)	0.048
Age (yr)
< 50	11/50 (22)	0.014	3/47 (6.4)	0.758
≥ 50	173/435 (39.8)	0.014	17/403 (4.2)	0.758
Location
Right colon	67/161 (41.6)	0.318	14/146 (9.6)	0.001
Left colon	50/150 (33.3)		3/167 (2.1)
Rectum	68/177 (38.4)		3/140 (1.8)
Mucin production
With	41/108 (38)	0.990	10/102 (9.8)	0.006
Without	144/380 (37.9)	0.990	10/351 (2.8)	0.006
Tumor differentiation
Poor	25/84 (29.8)	0.091	7/74 (9.5)	0.045
Well-moderate	160/404 (39.6)	0.091	13/379 (3.4)	0.045
Tumor stage
I-II	85/232 (36.6)	0.553	10/218 (4.6)	0.918
III-IV	97/247 (39.3)	0.553	10/228 (4.4)	0.918

Citation: Ye JX, Liu Y, Qin Y, Zhong HH, Yi WN, Shi XY. KRAS and BRAF gene mutations and DNA mismatch repair status in Chinese colorectal carcinoma patients. World J Gastroenterol 2015; 21(5): 1595-1605
URL: https://www.wjgnet.com/1007-9327/full/v21/i5/1595.htm
DOI: https://dx.doi.org/10.3748/wjg.v21.i5.1595